Effect of progestins on IGF-I serum level in estrogen-treated postmenopausal women;Die Auswirkungen von Gestagenen auf den IGF-I-Serumspiegel bei postmenopausalen Frauen unter Estrogentherapie

Zentralblatt fur Gynakologie

Volumn 119, Issue SUPPL. 2, 1997, Pages 7-11

  Campagnoli, C ^a   Biglia, Nicoletta ^b   Cantamessa, C ^a   Di Sario, Maria Maddalena ^a   Lesca, Laura ^a  

^a Ospedale Ginecologico Sant'Anna   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Estrogen; Estrogen replacement therapy (HRT); Growth hormone GH); Insulin like growth factor I (IGF I); Progestin

Indexed keywords

CONJUGATED ESTROGEN; DYDROGESTERONE; ESTRADIOL; ESTROGEN; GESTAGEN; GROWTH HORMONE; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C;

ADULT; CLINICAL TRIAL; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; REVIEW; SOMATOSTATIN BLOOD LEVEL; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; CLIMACTERIC; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PROGESTERONE CONGENERS; SEX HORMONE-BINDING GLOBULIN;

EID: 0030778759     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Bellantoni MF, Harman SM, Cho DE, Blackman MR: Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor I in postmenopausal women of different ages. J Clin Endocrinol Metab 72 (1991) 172-178
2. Campagnoli C, Biglia N, Altare F, Lanza MG, Lesca L, Cantamessa C, Peris C, Fiorucci GC, Sismondi P: Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor I, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol 7 (1993) 251-258
3. Campagnoli C, Biglia N, Lanza MG, Lesca L, Peris C, Sis- mondi P: Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report. Maturitas 19 (1994) 25-31
4. Campagnoli C, Biglia N, Peris C, Sismondi P: Potential impact on breast cancer risk of circulating insulin-like growth factor I modifications induced by oral HRT in menopause. Gynecol Endocrinol 9 (1995) 67-74
5. Campagnoli C, Biglia N, Sismondi P: Hormone replacement therapy and breast cancer risk (letter). JAMA 275 (1996) 1159
6. Clemmons DR, Underwood LE, Ridgeway EG, Kliman B, Kjellberg RN, Van Wyck JJ. Estradiol treatment of acromegaly: reduction of immunoreactive somatomedin C and improvement in metabolic status. Am J Med 69 (1980) 571-575
7. Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO: Both oral and transdermal estrogen increase growth hormone release in postmenopausal women. A clinical research center study. J Clin Endocrinol Metab 81 (1996) 2250-2256
8. Goodman-Gruen D, Barrett-Connor E: Effect of replacement estrogen on Insulin-Like Growth Factor-I in post-menopausal women: The Rancho Bernardo Study. J Clin Endocrinol Metab 81 (1996) 4268-4271
9. Hartmann B, Kirchengast S, Albrecht A, Laml T, Bikas D, Huber J: Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women. Maturitas 22 (1995) 239-246
10. Ho KKY, O'Sullivan AJ, Weissberger AJ, Kelly JJ: Sex steroid regulation of growth hormone secretion and action. Horm Res 45 (1996) 67-73
11. Iranmanesh A, Veldhuis JD: Clinical pathophysiology of the somatotropic (GH) axis in adults. Endocrinol Metab Clin N Am 21 (1992) 783-816
12. Kazer RR: Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int J Cancer 62 (1995) 403-406
13. Lieberman SA, Mitchell AM, Marcus R, Hintz RL, Hoffman AR: The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy. Horm Metab Res 26 (1994) 229-233
14. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, Lobo RA: A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 60 (1993) 664-667
15. Ravn P, Overgaard K, Spencer EM: Christiansen C: Insulin-like growth factors I and II in health women with and without established osteoporosis. Eur J Endocrinol 132 (1995) 313-319
16. Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z: Transdermal 17ß-estradiol combined wich oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women. J Endocrinol Invest 15 (1992) 533-538
17. Weissberger AJ, Ho KKY, Lazarus L: Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in post-menopausal women. J Clin Endocrinol Metab 72 (1991) 374-381